Why Has Hyperbaric Oxygen Therapy (HBOT) Not Widespread for COVID-19? Unveiling the Global Death Toll

In the midst of the global pandemic, a range of treatments and therapies have been examined in the quest for a cure for severe cases of COVID-19. Among them is Hyperbaric Oxygen Therapy (HBOT), a medical intervention that has the potential to save lives. Despite its potential, the world has largely ignored this option. This article explores the reasons behind this neglect and the implications for global death statistics.

The Potential of HBOT for Severe COVID-19 Cases

According to various studies, HBOT can be an effective treatment for individuals with severe cases of COVID-19. For instance, in a study conducted by the American Thoracic Society, it was observed that 80% of intubated patients could have survived with the use of HBOT. This high success rate suggests that HBOT could significantly reduce the mortality rate in severe cases.

Why Hasn't HBOT Become Widespread?

Despite its potential, HBOT has not become a widely embraced treatment for severe COVID-19 cases. There are several reasons behind this:

Specialized Equipment and Training

HBOT requires specialized equipment and trained staff. Most hospitals are better equipped with ventilators than HBOT tanks. This mismatch in resources makes it difficult for hospitals to switch to HBOT even when it might be more effective. Moreover, hiring and training staff for HBOT treatment is a time-consuming process, which is not feasible for patients who are critically ill.

Cost and Logistical Challenges

While the cost of HBOT is a significant concern, it is not the only factor. The logistical challenges include the need for specialized staff, the time required to train them, and the need for a pressure chamber. None of these are readily available or easy to implement in most hospitals, especially in regions with resource constraints.

Implications for Global Death Statistics

If HBOT had been widely available and utilized, the global death toll from COVID-19 might have been significantly lower. The potential of saving lives through HBOT is substantial, and its absence has led to a higher death rate, particularly among the severely ill. However, it is important to note that the absence of this treatment does not reflect a lack of effort or knowledge. Rather, it reflects a broader issue in the medical establishment.

The Medical Establishment's Role

The global medical establishment has a significant influence over which treatments are considered acceptable. This can lead to a situation where alternative treatments are ignored or even condemned. For instance, Dr. David Brownstein, a medical practitioner in Wisconsin, has developed effective treatments using vitamins A, C, D, ozone therapy, and hydrogen peroxide nebulization. However, his practices have been censored by the company managing his YouTube channel, highlighting the intense scrutiny faced by those who propose non-traditional treatments.

Alternatives to Traditional Medicine

While traditional medicine often takes precedence, there are alternative therapies that have shown promise. For example, Dr. W. C Douglass's Hydrogen Peroxide therapy, which can be administered without the need for specialized equipment, has gained attention. According to Douglass, nebulizing a dilute hydrogen peroxide solution can mimic the effects of HBOT.

A Personal Experience

Based on personal experience, nebulizing a dilute hydrogen peroxide solution can be an effective treatment for respiratory infections, including those caused by the flu or, theoretically, COVID-19. On April 2nd, I contracted a high fever, likely due to a flu or potential COVID-19. After two days of nebulizing with a dilute solution, my temperature dropped in hours, and I did not experience sinus, throat, or lung complications, which are typically common alongside such infections.

These experiences, combined with the documented benefits of hyperbaric oxygen therapy, suggest that alternative treatments can play a significant role in the fight against severe respiratory infections. However, the medical establishment's reluctance to adopt these treatments may lead to higher mortality rates, as seen in the case of COVID-19.